VCEL
Vericel Corporation
NASDAQ · USHealthcareBiotechnology
$45.88-1.63%
Price as of Jul 20, 2026
VCEL profitability
Vericel Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 74.8%
- EBITDA margin
- 12.1%
- EBIT margin
- 5.4%
- Net margin
- 7.3%
- Free cash flow margin
- 19.8%
Returns
- Return on equity
- 6.0%
- Return on assets
- 4.4%
- Return on invested capital
- 3.5%
- Asset turnover
- 0.60x
Cash efficiency
- Cash from operations
- $61.7M
- Cash per share
- $2.85
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.